drugset / Trial / NCT03258294

Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease

NCT03258294

RandomizedParallel-groupTriple-blindTreatment

Summary

This clinical study is a double-blind, randomized, placebo-controlled trial to investigate the effects of melatonin on the sleep disturbance symptoms of Parkinson's disease patients, symptoms which have a significant impact on the quality of life of these patients.

Timeline

Start
2016-01-13
Primary completion
2018-12-30
Completion
2018-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule Oral

Indications